Adult respiratory distress syndrome
Research conducted at Tongji University in Shanghai, People's Republic of China, has shed new light on the role of itaconate in inflammatory diseases, particularly in acute lung injury. According to the study, itaconate promotes the production of proinflammatory cytokines and augments the activation of the NACHT-, leucine-rich-repeat- (LRR)
Adult respiratory distress syndrome
A new study highlights the risks associated with ventilator-associated complications in COVID-19 patients, emphasizing the need for a safety protocol during extracorporeal membrane oxygenation (ECMO) insertion and careful assessment of bleeding risk in anticoagulated patients. The research, published in Forensic Science, Medicine and Pathology, details a case of a man
Adult respiratory distress syndrome
Research conducted at Tongji University in Shanghai, People's Republic of China, has shed new light on the role of itaconate in inflammatory diseases, revealing a previously unknown proinflammatory function in tissue-resident alveolar macrophages. The study, published in Cell Metabolism, found that itaconate promotes the production of proinflammatory cytokines
Adult respiratory distress syndrome
Researchers at the College of Medicine, Shaoxing Vocational & Technology College, have discovered that zerumbone, a cyclic sesquiterpene compound, can attenuate acute lung injury in mice by suppressing the NLRP3/Caspase-1/GSDMD signalling pathway. This finding highlights the potential of zerumbone as a novel therapeutic agent for the treatment of
Adult respiratory distress syndrome
Researchers at Fudan University in Shanghai, China have made a significant breakthrough in understanding the complexities of acute respiratory distress syndrome (ARDS). By conducting a multicenter cohort study with 1048 patients, they were able to identify three distinct inflammatory phenotypes (C1, C2, C3) using targeted serum proteomics. The study found
Adult respiratory distress syndrome
Researchers from Mahidol University in Thailand have investigated the correlation between mechanical power and clinical outcomes in mechanically ventilated patients. The study, published in BMJ Open Respiratory Research, aimed to determine mechanical power in patients admitted to the surgical intensive care unit (SICU) who required mechanical ventilation (MV) support. The
Adult respiratory distress syndrome
Researchers at Wenzhou Medical University have made a breakthrough in the development of a novel MyD88 inhibitor, 3g, which has shown significant potential in treating acute lung injury (ALI). According to the study, 3g is an orally bioavailable, tir domain selective, and potent MyD88 inhibitor that effectively mitigates ALI symptoms
Adult respiratory distress syndrome
Research conducted by the Faculty of Medicine at Nam Can Tho University has shed light on the complexities of using corticosteroids in non-viral acute respiratory distress syndrome (ARDS). According to the study, the 2024 global redefinition of ARDS has broadened diagnostic criteria to include patients on non-invasive respiratory support, introducing
Adult respiratory distress syndrome
Acute Respiratory Distress Syndrome (ARDS) is a life-threatening condition characterized by inflammation and lung damage. Researchers have been exploring alternative treatments, including the use of extracellular vesicles derived from mesenchymal stem cells (MSCs). A recent study published in Pharmaceutics has shed light on the potential of MSC-derived extracellular vesicles in
